Equities researchers at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research note issued on Saturday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Global Cord Blood stock opened at $1.75 on Friday. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The firm has a market capitalization of $212.71 million, a PE ratio of 2.73 and a beta of 0.16. The stock’s 50 day moving average price is $1.56 and its 200 day moving average price is $1.36.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- Health Care Stocks Explained: Why You Might Want to Invest
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- What is a Death Cross in Stocks?
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Breakout Stocks: What They Are and How to Identify Them
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.